UniProtKB/SwissProt variant VAR

Variant information

Variant position:

87

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

Disease [Disclaimer]

The variants are classified into three categories: Disease, Polymorphism and Unclassified.

Disease: Variants implicated in disease according to literature reports.
Polymorphism: Variants not reported to be implicated in disease.
Unclassified: Variants with uncertain implication in disease according to literature reports. Evidence against or in favor of a pathogenic role is limited and/or conflicting.

Residue change:

From Glutamate (E) to Glutamine (Q) at position 87 (E87Q, p.Glu87Gln).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and acidic (E) to medium size and polar (Q)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

2

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

Probable disease-associated variant found in a patient with non-specific cardiac conduction defects.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs121434627 [ dbSNP | Ensembl ]

Sequence information

Variant position:

87

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

218

The length of the canonical sequence.

Location on the sequence:

FVKILRYENEVLQLEEDERF E GRVVWNGSRGTKDLQDLSIF

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         FVKILRYENEVLQLEEDERFEGRVVWNGSRGTKDLQDLSIF

                              FVKILRYENEVLQLEEDERFEGRVVWNGSRGTKDLQDLSIF

Chimpanzee                    FVKILRYENEVLQLEEDERFEGRVVWNGSRGTKDLQDLSIF

Mouse                         FVKILRYENEVLQLEEDERFEGRVVWNGSRGTKDLQDLSIF

Rat                           FVKILRYENEVLQLEEDERFEGRVVWNGSRGTKDLQDLSIF

Bovine                        FVKILRYENEVLQLEEDERFEGRVVWNGSRGTKDLQDLSIF

Rabbit                        FVKILRYENEVLQLEEDERFEGRVVWNGSRGTKDLQDLSIF

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	19 – 218	Sodium channel subunit beta-1
Topological domain	19 – 160	Extracellular
Domain	22 – 150	Ig-like C2-type
Glycosylation	93 – 93	N-linked (GlcNAc...) asparagine
Disulfide bond	40 – 121
Beta strand	87 – 92

Literature citations

Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans.
Watanabe H.; Koopmann T.T.; Le Scouarnec S.; Yang T.; Ingram C.R.; Schott J.J.; Demolombe S.; Probst V.; Anselme F.; Escande D.; Wiesfeld A.C.; Pfeufer A.; Kaab S.; Wichmann H.E.; Hasdemir C.; Aizawa Y.; Wilde A.A.; Roden D.M.; Bezzina C.R.;
J. Clin. Invest. 118:2260-2268(2008)
Cited for: INVOLVEMENT IN BRGDA5; VARIANT GLN-87; FUNCTION;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q07699: Variant p.Glu87Gln